TransMedics Responds to Inaccurate and Misleading Claims in Recent Short-Seller Report

ANDOVER, Mass., Jan. 13, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today addressed what we believe are inaccurate and misleading claims made in a short-seller report issued by Scorpion Capital on January 10, 2025. In response, the company issued the following statement: We strongly believe that the claims made in the Scorpion Capital report ...